Genomic and proteomic analysis of the myeloid differentiation program

Z Lian1, L Wang, S Yamaga

  • 1Department of Genetics, Boyer Center for Molecular Medicine, Yale University School of Medicine, 295 Congress Ave., New Haven, CT 06536-0812, USA.

Blood
|July 27, 2001
PubMed

Insights

This study details gene expression changes during mouse myeloid differentiation using a retinoic acid-treated cell line. It identifies novel regulatory factors and highlights the importance of post-transcriptional events in neutrophil maturation.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Biology

Background:

  • Mature neutrophils are well-characterized, but myeloid differentiation mechanisms remain unclear at the molecular level.
  • Mouse promyelocytic cell line (MPRO) cells are developmentally arrested and can differentiate into neutrophils with retinoic acid treatment.

Purpose of the Study:

  • To catalog gene expression changes during MPRO cell differentiation into mature neutrophils.
  • To identify novel molecular players involved in myeloid differentiation.
  • To compare gene expression at mRNA and protein levels.

Main Methods:

  • 3'-end differential display
  • Oligonucleotide chip array hybridization
  • 2-dimensional protein electrophoresis

Main Results:

  • Identified a large number of genes with modulated mRNA levels during differentiation.
  • Suggested involvement of previously unrecognized transcription regulatory factors.
  • Highlighted the significance of non-transcription factor-related events.
  • Studied the correlation between mRNA and protein expression patterns.

Conclusions:

  • Myeloid differentiation involves complex gene expression modulation.
  • Novel transcription factors and other regulatory events contribute to neutrophil maturation.
  • mRNA and protein expression patterns show variable correlation during differentiation.